EYE

Medicare for All is back on Wall Street's radar. Democrats won control of both the House and Senate in the Nov. 3, 2026, midterm elections.

The new location brings every touchpoint together in one experience, making it easier than ever to shop, learn and receive care. ALPHARETTA, Ga.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Investors looking for stocks in the Consumer Products - Staples sector might want to consider either National Vision (EYE) or Colgate-Palmolive (CL). But which of these two companies is the best option for those looking for undervalued stocks?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

National Vision Holdings continues to deliver rising revenue, profits, and cash flow, with operational expansion and strategic investments fueling growth. EYE trades at a remarkably cheap valuation, both absolutely and relative to peers, justifying a maintained 'buy' rating despite recent market underperformance. Management is executing on four key initiatives: new store growth, managed care expansion, product innovation, and enhanced customer experience, supporting long-term value creation.

National Vision's premium-product demand and stronger customer mix support growth, but rising costs and vendor dependence remain key risks for investors.

National Vision (EYE) reported earnings 30 days ago. What's next for the stock?

Investors interested in Consumer Products - Staples stocks are likely familiar with National Vision (EYE) and Colgate-Palmolive (CL). But which of these two stocks offers value investors a better bang for their buck right now?

National Vision Holdings, Inc. (EYE) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript